Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.
Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital. The patients will be followed with standard clinical techniques (slit-lamp examination, refraction, topography) during their normal follow-up up to 12 months after treatment.
Study Type
OBSERVATIONAL
Enrollment
125
Department of Ophthalmology, Aarhus University Hospital
Aarhus C, Denmark
Effectiveness
Achieved change in refraction (spherical equivalent, SE) in diopters will be compared with attempted change in refraction (SE) in diopters. Data will be reported as fraction of eyes within an error (achieved - attempted) of +/- 0.5 diopters (SE) and within an error of +/- 1 diopters (SE).
Time frame: Refraction one year after surgery
Safety
Data will be reported as: * Percentage of eyes with best spectacle corrected visual acuity (BSCVA) worse than 20/40 for eyes with BSCVA of 20/20 or better before survey * Percentage of eyes that lose 2 Snellen lines or more of BSCVA
Time frame: One year after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.